Cite
HARVARD Citation
Papakonstantinou, A. et al. (2020). Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial. Cancer. 126 (6), pp. 1175-1182. [Online].